Enhanced early IgG-mediated complement deposition in the development of chronic chikungunya virus disease
Gosavi, M.; Kamphaugh, H.; Schmidt, H. M.; Callahan, V.; Dunagan, M. M.; Kwan, J. L.; Encinales, L.; Porras-Ramirez, A.; Rico-Mendoza, A.; Chang, A.; Fox, J. M.
Show abstract
Chikungunya virus (CHIKV) disease typically resolves following acute infection; however, some individuals develop chronic CHIKV disease (CCD) characterized by persistent, debilitating joint pain. Antibodies help clear CHIKV through neutralization and Fc effector functions. Previous studies have associated CCD with a poor neutralizing antibody response; however, the role of Fc effector functions in CCD development remains unclear. Here, purified IgG from post-acute serum of individuals who either resolved CHIKV disease or developed CCD was evaluated for IgG activity and Fc effector functions to identify correlations with disease progression and biomarkers for CCD. Resolution was associated with higher levels of CHIKV-specific IgG and IgG1 and stronger CHIKV neutralization. Regression analysis identified bulk IgG2 as a strong predictor of CHIKV disease progression. Development of CCD was associated with enhanced IgG-mediated complement deposition on infected cells. These findings suggest that localized complement activation at sites of infection may contribute to persistent inflammation underlying CCD.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- DENV-specific IgA contributes protective and non-pathologic function during antibody-dependent enhancement of DENV infection 93%
- Complement Decay-Accelerating Factor is a modulator of influenza A virus lung immunopathology 93%
- Life-long persistence of infectious Zika virus: Inflammation and behavioral sequela 92%
Similar papers in this journal
Similar papers in this journal
- A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge 92%
- Characterization of the First Complete Genome Sequence of Yellow Fever Virus (YFV) isolate in Sierra Leone: Implications for Public Health 91%
- Defining levels of dengue virus serotype-specific neutralizing antibodies induced by a live attenuated tetravalent dengue vaccine (TAK-003) 91%
Similar papers in this journal
- Population immunity to clade 2.3.4.4b H5N1 is dominated by anti-neuraminidase antibodies 92%
- Isolation of a potently neutralizing and protective human monoclonal antibody targeting yellow fever virus 92%
- Low levels of H5N1 HA and NA antibodies in the human population are boosted by seasonal A/H1N1 infection but not by A/H3N2 infection or influenza vaccination 91%
Similar papers in this journal
- The association of neutralizing antibodies with protection against symptomatic dengue virus infection varies by serotype, prior infection history, and assay condition 93%
- A systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of disease 93%
- SARS-CoV-2 Viral Load is Associated with Increased Disease Severity and Mortality 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.